Advisory Services Network’s Aratana Therapeutics, Inc. PETX Stock Holding History

Advisory Services Network’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,000	Closed	-$5K	–	3400
2019 Q3	$5K	Hold	1,000	–	–	﹤0.01%	2442
2019 Q2	$5K	Sell	1,000 -4,000	-80%	-$18K	﹤0.01%	2440
2019 Q1	$18K	Hold	5,000	–	–	﹤0.01%	1659
2018 Q4	$31K	Sell	5,000 -2,000	-29%	-$12.2K	﹤0.01%	1325
2018 Q3	$41K	Hold	7,000	–	–	﹤0.01%	1307
2018 Q2	$31K	Hold	7,000	–	–	﹤0.01%	1390
2018 Q1	$31K	Hold	7,000	–	–	﹤0.01%	1495
2017 Q4	$37K	Buy	7,000 +4,500	+180%	+$27.5K	﹤0.01%	1411
2017 Q3	$15K	Hold	2,500	–	–	﹤0.01%	1491
2017 Q2	$18K	Buy	+2,500	New	+$15.4K	﹤0.01%	1391

Advisory Services Network's PETX Position: Q4 2019 in Review

Advisory Services Network sold out of Aratana Therapeutics, Inc. (PETX) in Q4 2019, closing a stake of 1,000 shares — an estimated $5K sold.

Advisory Services Network first reported a position in PETX in Q2 2017 and held it in 10 quarters. The position peaked at $41K in Q3 2018. 0 funds tracked by Wall St. Rank hold PETX as of Q4 2019.

Advisory Services Network reported no remaining Aratana Therapeutics, Inc. position as of Q4 2019 after selling out during the quarter.
Advisory Services Network sold 1,000 Aratana Therapeutics, Inc. shares in Q4 2019, an estimated $5K.
Advisory Services Network first reported a position in Aratana Therapeutics, Inc. in Q2 2017 and held it in 10 quarters.
Advisory Services Network's Aratana Therapeutics, Inc. position peaked at $41K in Q3 2018.
0 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q4 2019.

Based on Advisory Services Network's 13F filing for Q4 2019, filed 4 Feb 2020.